Benefit of repeated COVID-19 vaccination for patients with B-cell malignancies

Br J Haematol. 2023 Sep;202(6):1081-1083. doi: 10.1111/bjh.19005. Epub 2023 Jul 30.

Authors

Ulrike Bacher¹, Evgenii Shumilov², Thomas Pabst³

Affiliations

¹ Department of Hematology, University Hospital Inselspital and University of Bern, Bern, Switzerland.
² Department of Medicine A, Hematology, Oncology and Pneumology, University Hospital Muenster, Muenster, Germany.
³ Department of Medical Oncology, University Hospital Inselspital and University of Bern, Bern, Switzerland.

PMID: 37519052
DOI: 10.1111/bjh.19005

No abstract available

Keywords: B-cell depletion; B-cell malignancies; COVID-19 vaccine.

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Antibodies, Viral
COVID-19 Vaccines*
COVID-19* / prevention & control
Humans
Vaccination

Substances

COVID-19 Vaccines
Antibodies, Viral